At a glance
ClinicalIndex Comparison RecordN/ACompleted· 85 enrolled
Drug / intervention
Adaptive DBSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD)
In Brief
A clinical study evaluating Adaptive DBS for Parkinson Disease. Completed, enrolled 85 participants across 10 sites in 4 countries.
Detailed Summary
The purpose of the study is to demonstrate the safety and effectiveness of adaptive DBS (aDBS) for Parkinson's disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesCanada, France, Netherlands, United States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedSep 2020
Enrollment StartDec 2020
Primary CompletionJan 2023
Study CompletionMay 2025
TodayJul 2026
First PostedSep 14, 2020
Enrollment StartDec 14, 2020
Primary CompletionJan 12, 2023
Study CompletionMay 2, 2025
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 5.8 years ago
Interventions
Adaptive DBSdevice
Subjects for whom both aDBS modes are acceptable will receive Dual and Single Threshold aDBS